World

Top 413 largest Companies in the Drug Manufacturers—Specialty & Generic industry in the World by Market Cap

This is the list of the largest public listed companies in the Drug Manufacturers—Specialty & Generic industry in the world by market capitalization with links to their reference stock.

World Drug Manufacturers—Specialty & Generic Industry Analysis
World Top Companies World Companies Analysis

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jan. 01, 2025

Rank Company Market Cap (USD) Country Sector Industry
211 Cipher Pharmaceuticals Inc. $261.4 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
212 Orient Pharma Co. Ltd $250.7 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
213 Fuji Pharma Co. Ltd $240.0 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
214 Aurora Cannabis Inc. $235.8 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
215 Handa Pharmaceuticals, Inc. $231.6 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
216 Ildong Pharmaceutical Co. Ltd $230.8 M South Korea South Korean Healthcare South Korean Drug Manufacturers—Specialty & Generic
217 Shaanxi Kanghui Pharmaceutical Co. Ltd $227.2 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
218 Dawnrays Pharmaceutical $226.0 M Hong Kong HK Healthcare HK Drug Manufacturers—Specialty & Generic
219 Beximco Pharmaceuticals Limited $215.5 M Bangladesh Bangladesh Healthcare Bangladesh Drug Manufacturers—Specialty & Generic
220 Laboratorio Reig Jofre, SA $215.0 M Spain Spanish Healthcare Spanish Drug Manufacturers—Specialty & Generic
221 EQL Pharma AB $214.1 M Sweden Swedish Healthcare Swedish Drug Manufacturers—Specialty & Generic
222 China Chemical & Pharmaceutical Co. Ltd $211.1 M

(July 1, 2024)

 Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
223 AFT Pharmaceuticals Limited $204.7 M

(July 1, 2024)

 New Zealand NZ Healthcare NZ Drug Manufacturers—Specialty & Generic
224 PT Kimia Farma $204.2 M Indonesia Indonesian Healthcare Indonesian Drug Manufacturers—Specialty & Generic
225 Labomar S.p.A. $201.8 M

(July 1, 2023)

 Italy Italian Healthcare Italian Drug Manufacturers—Specialty & Generic
226 Gage Growth Corp $193.8 M

(March 1, 2022)

 Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
227 Columbia Care, Inc. $192.6 M

(July 1, 2023)

 United States US Healthcare US Drug Manufacturers—Specialty & Generic
228 Mizuho Medy Co.,Ltd. $186.3 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
229 Elion Energy Company Ltd $186.2 M

(July 1, 2024)

 China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
230 Hua Medicine $176.8 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
231 Fine Foods & Pharmaceuticals N.T.M. S.p.A. $176.8 M Italy Italian Healthcare Italian Drug Manufacturers—Specialty & Generic
232 Lincoln Pharmaceuticals Ltd $175.7 M India Indian Healthcare Indian Drug Manufacturers—Specialty & Generic
233 RIV Capital Inc. $170.8 M

(Aug. 1, 2021)

 Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
234 REYON Pharmaceutical Co. Ltd $166.7 M South Korea South Korean Healthcare South Korean Drug Manufacturers—Specialty & Generic
235 Pharma Foods International Co. Ltd $166.7 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
236 Organigram Holdings Inc. $163.8 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
237 Koa Shoji Holdings Co.,Ltd. $162.7 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
238 Probiotec Limited $160.1 M

(Jan. 1, 2024)

 Australia Australian Healthcare Australian Drug Manufacturers—Specialty & Generic
239 PhotoCure ASA $148.3 M

(July 1, 2024)

 Norway Norway Healthcare Norway Drug Manufacturers—Specialty & Generic
240 HAEMATO AG $144.4 M

(Jan. 1, 2024)

 Germany German Healthcare German Drug Manufacturers—Specialty & Generic

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jan. 01, 2025

211. Cipher Pharmaceuticals Inc.

Company Profile: Cipher Pharmaceuticals Inc.
Market Cap (USD): $261.4 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

212. Orient Pharma Co. Ltd

Company Profile: Orient Pharma Co. Ltd
Market Cap (USD): $250.7 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

213. Fuji Pharma Co. Ltd

Company Profile: Fuji Pharma Co. Ltd
Market Cap (USD): $240.0 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

214. Aurora Cannabis Inc.

Company Profile: Aurora Cannabis Inc.
Market Cap (USD): $235.8 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

215. Handa Pharmaceuticals, Inc.

Company Profile: Handa Pharmaceuticals, Inc.
Market Cap (USD): $231.6 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

216. Ildong Pharmaceutical Co. Ltd

Company Profile: Ildong Pharmaceutical Co. Ltd
Market Cap (USD): $230.8 M
Country: South Korea
Sector: South Korean Healthcare
Industry: South Korean Drug Manufacturers—Specialty & Generic

217. Shaanxi Kanghui Pharmaceutical Co. Ltd

Company Profile: Shaanxi Kanghui Pharmaceutical Co. Ltd
Market Cap (USD): $227.2 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

218. Dawnrays Pharmaceutical

Company Profile: Dawnrays Pharmaceutical
Market Cap (USD): $226.0 M
Country: Hong Kong
Sector: HK Healthcare
Industry: HK Drug Manufacturers—Specialty & Generic

219. Beximco Pharmaceuticals Limited

Company Profile: Beximco Pharmaceuticals Limited
Market Cap (USD): $215.5 M
Country: Bangladesh
Sector: Bangladesh Healthcare
Industry: Bangladesh Drug Manufacturers—Specialty & Generic

220. Laboratorio Reig Jofre, SA

Company Profile: Laboratorio Reig Jofre, SA
Market Cap (USD): $215.0 M
Country: Spain
Sector: Spanish Healthcare
Industry: Spanish Drug Manufacturers—Specialty & Generic

221. EQL Pharma AB

Company Profile: EQL Pharma AB
Market Cap (USD): $214.1 M
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Drug Manufacturers—Specialty & Generic

222. China Chemical & Pharmaceutical Co. Ltd

Company Profile: China Chemical & Pharmaceutical Co. Ltd
Market Cap (USD): $211.1 M (July 1, 2024)
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

223. AFT Pharmaceuticals Limited

Company Profile: AFT Pharmaceuticals Limited
Market Cap (USD): $204.7 M (July 1, 2024)
Country: New Zealand
Sector: NZ Healthcare
Industry: NZ Drug Manufacturers—Specialty & Generic

224. PT Kimia Farma

Company Profile: PT Kimia Farma
Market Cap (USD): $204.2 M
Country: Indonesia
Sector: Indonesian Healthcare
Industry: Indonesian Drug Manufacturers—Specialty & Generic

225. Labomar S.p.A.

Company Profile: Labomar S.p.A.
Market Cap (USD): $201.8 M (July 1, 2023)
Country: Italy
Sector: Italian Healthcare
Industry: Italian Drug Manufacturers—Specialty & Generic

226. Gage Growth Corp

Company Profile: Gage Growth Corp
Market Cap (USD): $193.8 M (March 1, 2022)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

227. Columbia Care, Inc.

Company Profile: Columbia Care, Inc.
Market Cap (USD): $192.6 M (July 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

228. Mizuho Medy Co.,Ltd.

Company Profile: Mizuho Medy Co.,Ltd.
Market Cap (USD): $186.3 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

229. Elion Energy Company Ltd

Company Profile: Elion Energy Company Ltd
Market Cap (USD): $186.2 M (July 1, 2024)
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

230. Hua Medicine

Company Profile: Hua Medicine
Market Cap (USD): $176.8 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

231. Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Company Profile: Fine Foods & Pharmaceuticals N.T.M. S.p.A.
Market Cap (USD): $176.8 M
Country: Italy
Sector: Italian Healthcare
Industry: Italian Drug Manufacturers—Specialty & Generic

232. Lincoln Pharmaceuticals Ltd

Company Profile: Lincoln Pharmaceuticals Ltd
Market Cap (USD): $175.7 M
Country: India
Sector: Indian Healthcare
Industry: Indian Drug Manufacturers—Specialty & Generic

233. RIV Capital Inc.

Company Profile: RIV Capital Inc.
Market Cap (USD): $170.8 M (Aug. 1, 2021)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

234. REYON Pharmaceutical Co. Ltd

Company Profile: REYON Pharmaceutical Co. Ltd
Market Cap (USD): $166.7 M
Country: South Korea
Sector: South Korean Healthcare
Industry: South Korean Drug Manufacturers—Specialty & Generic

235. Pharma Foods International Co. Ltd

Company Profile: Pharma Foods International Co. Ltd
Market Cap (USD): $166.7 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

236. Organigram Holdings Inc.

Company Profile: Organigram Holdings Inc.
Market Cap (USD): $163.8 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

237. Koa Shoji Holdings Co.,Ltd.

Company Profile: Koa Shoji Holdings Co.,Ltd.
Market Cap (USD): $162.7 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

238. Probiotec Limited

Company Profile: Probiotec Limited
Market Cap (USD): $160.1 M (Jan. 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Drug Manufacturers—Specialty & Generic

239. PhotoCure ASA

Company Profile: PhotoCure ASA
Market Cap (USD): $148.3 M (July 1, 2024)
Country: Norway
Sector: Norway Healthcare
Industry: Norway Drug Manufacturers—Specialty & Generic

240. HAEMATO AG

Company Profile: HAEMATO AG
Market Cap (USD): $144.4 M (Jan. 1, 2024)
Country: Germany
Sector: German Healthcare
Industry: German Drug Manufacturers—Specialty & Generic

Stay in touch